Takeshi Murata

9PUBLICATIONS
25CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 01, 2026
De-escalation of breast surgery for early stage breast cancer.

|Jun 21, 2026
Prognostic impact of progesterone receptor status in patients with breast cancer and isolated locoregional recurrence.

|Jun 11, 2026
Safety and Effectiveness of an Integrative Treatment of Acupuncture-Based Intervention in Survivors of Breast Cancer With Postmastectomy Pain Syndrome: Protocol for a Single-Center, Single-Arm Exploratory Trial.

|May 23, 2026
Prognosis of patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, 1-3 node-positive breast cancer meeting the high-risk criteria of the monarchE trial: a comparison between macrometastasis and micrometastasis.

|Nov 11, 2023
Prognostic impact of HER2-low positivity in patients with HR-positive, HER2-negative, node-positive early breast cancer.

Shohei Shikata, Takeshi Murata, Masayuki Yoshida

|Aug 23, 2023
Assessment of nuclear grade-based recurrence risk classification in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, node-positive high-risk early breast cancer.

Takeshi Murata, Masayuki Yoshida, Sho Shiino

Pageof 2

Frequent Collaborators

1 joint publications

Naruaki Kawasaki

1 joint publications

Hiroto Ishiki

1 joint publications

Naho Matsubara

1 joint publications

Takako Ikegami